These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34976467)

  • 1. Beyond the Skin Plaques: Psoriasis and Its Cardiovascular Comorbidities.
    Kakarala CL; Hassan M; Belavadi R; Gudigopuram SVR; Raguthu CC; Gajjela H; Kela I; Sange I
    Cureus; 2021 Nov; 13(11):e19679. PubMed ID: 34976467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.
    Furue M; Tsuji G; Chiba T; Kadono T
    Intern Med; 2017; 56(13):1613-1619. PubMed ID: 28674347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis.
    Egeberg A; Gisondi P; Carrascosa JM; Warren RB; Mrowietz U
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1695-1706. PubMed ID: 32022950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis.
    Cai J; Cui L; Wang Y; Li Y; Zhang X; Shi Y
    Front Pharmacol; 2021; 12():774808. PubMed ID: 34803716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.
    Guttman-Yassky E; Krueger JG; Lebwohl MG
    Exp Dermatol; 2018 Apr; 27(4):409-417. PubMed ID: 28266782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic disorders in patients with psoriasis].
    Sikora-Grabka E; Adamczak M; Wiecek A
    Przegl Lek; 2011; 68(12):1193-8. PubMed ID: 22519279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiometabolic comorbidities and the approach to patients with psoriasis.
    Gisondi P; Girolomoni G
    Actas Dermosifiliogr; 2009 Dec; 100 Suppl 2():14-21. PubMed ID: 20096157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.
    Ryan C; Leonardi CL; Krueger JG; Kimball AB; Strober BE; Gordon KB; Langley RG; de Lemos JA; Daoud Y; Blankenship D; Kazi S; Kaplan DH; Friedewald VE; Menter A
    JAMA; 2011 Aug; 306(8):864-71. PubMed ID: 21862748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis a Cause of Cardiovascular Diseases: A Review Article.
    Gupta A; Madke B
    Cureus; 2022 Aug; 14(8):e27767. PubMed ID: 36106203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis and metabolic syndrome.
    Takahashi H; Iizuka H
    J Dermatol; 2012 Mar; 39(3):212-8. PubMed ID: 22035413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic syndrome in patients with psoriasis].
    Wolska K; Michalska-Jakubus M; Pietrzak A; Krasowska D
    Pol Merkur Lekarski; 2014 Mar; 36(213):215-9. PubMed ID: 24779224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anti-inflammatory therapies to reduce cardiovascular burden of psoriasis.
    Piros ÉA; Szilveszter B; Vattay B; Maurovich-Horvat P; Szalai K; Dósa E; Merkely B; Holló P
    Dermatol Ther; 2021 Jan; 34(1):e14721. PubMed ID: 33373079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences.
    Boehncke WH
    Front Immunol; 2018; 9():579. PubMed ID: 29675020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concept of psoriasis as a systemic inflammation: implications for disease management.
    Reich K
    J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.